• No results found

Sclerosing cholangitis

Variation in Microbiome Composition and Stability for a Vancomycin Treated Primary Sclerosing Cholangitis Patient with Ulcerative Colitis Compared with Controls

Variation in Microbiome Composition and Stability for a Vancomycin Treated Primary Sclerosing Cholangitis Patient with Ulcerative Colitis Compared with Controls

... The bacterial composition of the human intestines contributes to much more than just digestion. In the in- flammatory autoimmune conditions primary sclerosing cholangitis (PSC) and ulcerative colitis (UC), ...

9

Normalization of Serum Alkaline Phosphatase in Primary Sclerosing Cholangitis Associated with Ulcerative Colitis

Normalization of Serum Alkaline Phosphatase in Primary Sclerosing Cholangitis Associated with Ulcerative Colitis

... [8] Chiba, M., Abe, T., Tsuda, H., et al. (2010) Lifestyle-Related Disease in Crohn’s Disease: Relapse Prevention by a Semi-Vegetarian Diet. World Journal of Gastroenterology, 16, 2484-2495. ...

6

Effect of the specific carbohydrate diet on the microbiome of a Primary Sclerosing Cholangitis and Ulcerative Colitis patient

Effect of the specific carbohydrate diet on the microbiome of a Primary Sclerosing Cholangitis and Ulcerative Colitis patient

... Routine blood tests over a four-month time period, when the patient was 16, detected increasingly elevated gamma-glutamyl transpeptidase, alanine transaminase, and aspartate transaminase activity. primary ...

7

Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients

Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients

... The true prevalence of SSC-CIP is hard to estimate since the disease still is not well known and is thus under- diagnosed in many areas. Systematic reporting of diag- nosed cases is also lacking. Unfortunately, our ...

12

Improving Symptoms of Primary Sclerosing Cholangitis by Iranian Traditional Medicine

Improving Symptoms of Primary Sclerosing Cholangitis by Iranian Traditional Medicine

... rimary Sclerosing Cholangitis (PSC) is a chronic cholestatic disease caused by inflammatory destruction as well as intra- and extra-hepatic biliary fibrosis which can lead to cirrhosis, liver transplant, ...

6

Secondary sclerosing cholangitis in critically ill patients: current perspectives

Secondary sclerosing cholangitis in critically ill patients: current perspectives

... Secondary sclerosing cholangitis (SSC) is a term used for a group of chronic chole- static disease affecting the intra- and/or extrahepatic biliary tree with inflammation and progres- sive stricture ...

7

A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients

A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients

... biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are hepatobiliary autoimmune diseases with strong genetic risk components ...

9

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

... Primary sclerosing cholangitis (PSC) is a chronic chole- static liver disease of unknown etiology [1] characterized by classic findings of multiple segmental strictures in the intra- and extra-hepatic bile ...

7

Association between serum IgG level and clinical course in primary sclerosing cholangitis

Association between serum IgG level and clinical course in primary sclerosing cholangitis

... (95% CI 0.6–0.7; p = 0.002) for MELD at first diagno- sis, compared to 0.71 (95% CI 0.6–0.8; p < 0.001) for serum IgG level at first diagnosis of PSC (Fig. 2). Patients with elevated IgG levels were significantly ...

10

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol

... Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single- arm, two-stage, open-lab[r] ...

8

A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis

A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis

... This systematic review is reported according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline (Supporting information 1) [38]. We searched four electronic databases (PubMed, ...

13

Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature

Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature

... Autoimmune sclerosing cholangitis is an overlap syndrome characterized by features of both autoimmune hepatitis and primary sclerosing cholangitis, the latter usually involving the large bile ...

6

Bardet-Biedl Syndrome, Crohn Disease, Primary Sclerosing Cholangitis, and Autoantibody Positive Thyroiditis: A Case Report and A Review of a Cohort of BBS Patients

Bardet-Biedl Syndrome, Crohn Disease, Primary Sclerosing Cholangitis, and Autoantibody Positive Thyroiditis: A Case Report and A Review of a Cohort of BBS Patients

... and chronic autoimmune disorders, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC), and Hashimoto thyroiditis (HT) has been reported to date. Herein, we report the case of an ...

6

Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis

Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis

... Extensive population-based studies are much needed to accurately establish epidemiology and disease course in patients with primary sclerosing cholangitis (PSC). We aimed to obtain population-based ...

11

The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report

The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report

... biliary cholangitis and primary sclerosing cholangitis in whom 28 months of adalimumab treatment improved the symptoms of the inflammatory arthropathy as well as those of both ...

5

Primary Sclerosing Cholangitis in Children: Study of Five Cases and Review of the Literature

Primary Sclerosing Cholangitis in Children: Study of Five Cases and Review of the Literature

... Although of relatively fre- quent occurrence in adults,’5 primary sclerosing cholangitis is a rare cause of chronic progressive liver disease in children.424 The purpose of this paper is[r] ...

8

Percutaneous Transhepatic Cholangioscopy and Lithotripsy for Intrahepatic Biliary Stones and Sclerosing Cholangitis Secondary to Kasai Procedure for Biliary Atresia: A Case Report

Percutaneous Transhepatic Cholangioscopy and Lithotripsy for Intrahepatic Biliary Stones and Sclerosing Cholangitis Secondary to Kasai Procedure for Biliary Atresia: A Case Report

... of cholangitis over the last ...sporadic cholangitis occurring approximately once a ...recurrent cholangitis necessitating repeated courses of intravenous antibiotics and ...in sclerosing ...

5

Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis

Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis

... Primary sclerosing cholangitis (PSC) is a chronic chole- static liver disease characterised by diffuse inflammation, fibrosis and sclerosis of intra- and/or extrahepatic bile ducts ...

12

Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report

Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report

... pancreas. IgG4-SC is the sixth most common type of organ involvement [14]. IgG4-SC is a characteristic type of sclerosing cholangitis with dense infiltration of IgG4- positive plasma cells and extensive ...

7

Primary sclerosing cholangitis

Primary sclerosing cholangitis

... Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology characterised by inflammation and fibrosis of the biliary ...

7

Show all 220 documents...

Related subjects